BPC-157 + TB-500 + KPV Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: repair and inflammatory signaling research

Structural Blend blend Blend verified

Also known as: BPC/TB/KPV

Quick Facts

Reference Sizes
20 mg total (5 mg BPC-157 + 10 mg TB-500 + 5 mg KPV), vendor-reported, 30 mg total (10 mg each), vendor-reported
Components
BPC-157 + TB-500 + KPV
Calculator
Preset available
Storage
Use source-label storage wording. Track lot, storage location, and open/reconstitution date.
Solubility
No published three-component compatibility study

Blend Components

This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.

Component
BPC-157
Calculator Profile
Component
TB-500
Calculator Profile
Component
KPV
Calculator Profile
Open All in Blend Calculator

Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.

Catalog Description

BPC-157, TB-500, and KPV are sold together in inconsistent fixed ratios. Component studies do not establish that co-lyophilization preserves identity or activity, and no controlled human or animal trial evaluates the marketed triple blend. TB-500 also must not inherit clinical claims from full-length thymosin beta-4.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
No fixed-blend pharmacokinetic study
Onset
Not established
Administration Routes (Research)
SC in marketed or community products onlyNo validated clinical route

Reported Research Effects

Reported Research Side Effects

Data source: FDA safety materials, component studies, current vendor lists, and community checks

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

Research Notes

Current market documents show both 20 mg and 30 mg totals with different component ratios. A total-mass label alone is insufficient; the site should display each component amount.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

FDA 2026 advisory meeting materials for BPC-157 KPV and TB-500 — U.S. Food and Drug Administration
https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026
Oral targeted KPV delivery in a mouse colitis model — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/28143741/

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Articles

Published articles on this site that mention BPC-157 + TB-500 + KPV or one of its catalog aliases.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top